Page last updated: 2024-09-03

substance p (5-11), pglu(5)-mephe(8)-megly(9)- and oxidopamine

substance p (5-11), pglu(5)-mephe(8)-megly(9)- has been researched along with oxidopamine in 3 studies

Compound Research Comparison

Studies
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
Trials
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
Recent Studies (post-2010)
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
47008,63062,407

Protein Interaction Comparison

ProteinTaxonomysubstance p (5-11), pglu(5)-mephe(8)-megly(9)- (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, PJ; Lorens, SA; Mitsushio, H; Paris, JM1
Iversen, SD1
Huston, JP; Nikolaus, S; Schwarting, RK1

Reviews

1 review(s) available for substance p (5-11), pglu(5)-mephe(8)-megly(9)- and oxidopamine

ArticleYear
Behavioural effects of substance P through dopaminergic pathways in the brain.
    Ciba Foundation symposium, 1982, Issue:91

    Topics: Animals; Behavior, Animal; Dextroamphetamine; Diencephalon; Dopamine; Drug Stability; Endopeptidases; Exploratory Behavior; Hydroxydopamines; Limbic System; Metalloendopeptidases; Motor Activity; Neural Pathways; Neurons; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Substance P; Telencephalon

1982

Other Studies

2 other study(ies) available for substance p (5-11), pglu(5)-mephe(8)-megly(9)- and oxidopamine

ArticleYear
Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
    Pharmacology, biochemistry, and behavior, 1990, Volume: 37, Issue:2

    Topics: Animals; Brain; Catheterization; Cerebral Ventricles; Chromatography, High Pressure Liquid; Haloperidol; Hydroxydopamines; Infusions, Parenteral; Male; Motor Activity; Muscimol; Neurons; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Substance P; Tegmentum Mesencephali

1990
Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion.
    Neural plasticity, 1999, Volume: 6, Issue:4

    Topics: Animals; Corpus Striatum; Dopamine; Functional Laterality; Male; Motor Activity; Oxidopamine; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Substance P; Substantia Nigra; Tetragastrin

1999